Search Results
Viewing: 161-170 of 283 | All
News
Jerry Mendell, MD, Announced as King Faisal Prize Laureate in Medicine
Jerry Mendell, MD, senior advisor in the Center for Gene Therapy in the Abigail Wexner Research Institute at Nationwide Children’s Hospital, is this year’s recipient of the King Faisal Prize for Medicine for his contributions toward the screening, diagnosis and treatment of neuromuscular diseases, including spinal muscular atrophy (SMA), Duchenne muscular dystrophy (DMD) and limb girdle muscular dystrophy.
News
Patrick Gallagher, MD, Elected to Association of American Physicians
Patrick Gallagher, MD, director of the Center for Perinatal Research in the Abigail Wexner Research Institute at Nationwide Children’s Hospital, has been elected to the Association of American Physicians, one of the most prestigious physician-scientist societies worldwide. Dr. Gallagher is the first physician from Nationwide Children’s to be elected to the association.
Article
Training and Experience
Learn more about the training and experience you will receive as a Hematology, Oncology and BMT fellow.
News
Nationwide Children’s Hospital Announces Two New Vice Presidents to Advance Population Health Efforts
As Nationwide Children’s Hospital continues to accelerate our commitment to population health locally and regionally, two successful internal leaders have been tapped for expanded leadership roles.
Article
Dougherty Lab Staff
Kylie Dougherty, PhD, RN Principal Investigator and Nurse Scientist Kylie.Dougherty@NationwideChildrens.org Kylie Dougherty, PhD, RN is a Nurse Scientist in the Center for Nursing Excellence at Nationwide Children’s Hospital and an Associate faculty member in the Center for Child Health
News
Early Phase Gene Therapy Study for SMARD1/CMT2S Disease Now Enrolling
Nationwide Children's Hospital has launched a new Phase I/IIa gene replacement clinical study to evaluate the safety of a gene therapy for IGHMBP2-related diseases, specifically spinal muscular atrophy with respiratory distress type 1 (SMARD1) and Charcot Marie Tooth disease type 2S (CMT2S). SMARD1 and CMT2S are rare inherited conditions that are both caused by mutations in the IGHMBP2 gene, of which more than 60 have been found to date. SMARD1 is the most severe form of these diseases and causes muscle weakness and respiratory failure in infancy.
News
Dr. Can Yerebakan Named Associate Chief of the Department of Cardiothoracic Surgery
Nationwide Children’s Hospital has named Can Yerebakan, MD, PhD, as the associate chief of the Department of Cardiothoracic Surgery and director of the Congenital CT Surgery Fellowship. Dr. Yerebakan is a principal investigator in the Center for Cardiovascular Research.
News
Nationwide Children’s Hospital and the City of Columbus Bringing Comprehensive Injury-Prevention Program to Central Ohio Children
(COLUMBUS, Ohio) – Nationwide Children’s Hospital and the City of Columbus are hosting the Safety City Columbus injury-prevention program for the second straight summer. The program returned in 2022 after a more than 30-year hiatus within the city’s limits.
News
From Bench to Bedside: Patient with Duchenne Muscular Dystrophy Receives First Dose of Gene Therapy Developed at Nationwide Children’s Hospital
In a landmark moment for the Abigail Wexner Research Institute at Nationwide Children’s, a 5-year-old from Bellefontaine, Ohio, received the first dose of a recently approved gene therapy for Duchenne muscular dystrophy at Nationwide Children’s Hospital, where the therapy was invented and initially tested.
News
Mapping the 3D Structure of Rhabdomyosarcoma Chromatin
In a paper published in Nucleic Acids Research Cancer (NAR Cancer), researchers from the Center for Childhood Cancer Research at Nationwide Children’s and their collaborators report a comprehensive 3D chromatin structural analysis and characterization of rhabdomyosarcoma (RMS).